FSMAX
Price
$94.94
Change
+$0.66 (+0.70%)
Updated
Nov 8 closing price
MEFFX
Price
$16.47
Change
+$0.08 (+0.49%)
Updated
Nov 8 closing price
Ad is loading...

FSMAX vs MEFFX

Header iconFSMAX vs MEFFX Comparison
Open Charts FSMAX vs MEFFXBanner chart's image
Fidelity Extended Market Index
Price$94.94
Change+$0.66 (+0.70%)
VolumeN/A
CapitalizationN/A
MassMutual Mid Cap Growth R4
Price$16.47
Change+$0.08 (+0.49%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSMAX vs MEFFX Comparison Chart
Loading...
VS
FSMAX vs. MEFFX commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and MEFFX is a StrongSell.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. MEFFX (5.18B). FSMAX pays higher dividends than MEFFX: FSMAX (1.10) vs MEFFX (0.00). FSMAX was incepted earlier than MEFFX: FSMAX (13 years) vs MEFFX (11 years). MEFFX is a more actively managed with annual turnover of: 32.00 vs. FSMAX (18.00). FSMAX (0) and MEFFX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 45.37 vs. MEFFX (23.28). FSMAX return over 5 years is better than : 56.24 vs. MEFFX (-17.90).
FSMAXMEFFXFSMAX / MEFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years11 years-
Gain YTD21.62415.014144%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets40B5.18B772%
Annual Yield % from dividends1.100.00-
Returns for 1 year45.3723.28195%
Returns for 3 years2.38-39.80-6%
Returns for 5 years56.24-17.90-314%
Returns for 10 years86.33-10.00-863%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UBFO9.070.06
+0.67%
United Security Bancshares
ATAT26.55-0.15
-0.56%
Atour Lifestyle Holdings Limited
EFSH0.24N/A
-0.95%
1847 Holdings LLC
RPRX26.21-0.31
-1.17%
Royalty Pharma plc
FLGT19.43-2.59
-11.76%
Fulgent Genetics